Why Us

  • Global Branch Around the World

The First Fertility Group (FFG) was founded by a Hong Kong based entrepreneur Mr. Alfred Siu.

Mr. Alfred Siu, the managing director of First Fertility Group, was educated in Stanford University, and had started many successful businesses, including a construction business which was publicly listed in Hong Kong, Australia, and Nasdaq. Mr. Siu was awarded the Young Entrepreneur Award organized by DHL and SCMP in 1994.

Mr. Siu started the first IVF clinic, the First Fertility PGD Center Limited, in Bangkok Thailand in 2014.

One year later, he exported the expertise from Thailand to Cambodia, and started the First Fertility Phnom Penh clinic in 2015. The two clinics enjoyed steady growth, and performed close to 900 patient cycles in 2019.

In 2019, First Fertility Group became the bigger family with the mission to help more patients who suffers from the failure and cannot carry their baby. Our First Fertility Bishkek was established in October 2019 for surrogacy program.

  • Legal Clinic License

We got the license for Gynecologist and IVF treatment from government to have the legal treatment for surrogate mother with high pregnancy rate.

  • Legal Surrogate program

Surrogacy law in Kyrgyzstan

GOVERNMENT OF THE KYRGYZ REPUBLIC RESOLUTION

Dated: July 23, 2018 No. 337

On approval of individual acts in the field of using assisted reproductive technologies

In order to implement Articles 18 – 21 of the Law of the Kyrgyz Republic “On reproductive rights and guarantees of their realization”, in accordance with Articles 10 and 17 of the constitutional Law of the Kyrgyz Republic “About the Government of the Kyrgyz Republic” the Government of the Kyrgyz Republic

DECIDES:

  1. Approve:
  • The procedure and conditions for the use of the method of surrogacy in accordance with Appendix 1;
  • The procedure and conditions for donation of germ cells, as well as storage and conditions for the use of germ cells in accordance with Appendix 2;
  • The procedure for artificial insemination in accordance with Appendix 3;
  • The list of medical indications for the reduction in accordance with Appendix 4.
  1. This resolution becomes effective after ten days from the date of official publication.

ORDER AND CONDITIONS of
using the surrogacy

Chapter 1. General Provisions

  1. This Procedure and conditions for using the method of surrogate motherhood governs the procedure and conditions for using the method of surrogate motherhood for bearing a child.
  2. Surrogate motherhood is the bearing and birth of a child (including premature birth) under a surrogacy agreement concluded between a surrogate mother (a woman bearing a fetus after transferring a donor embryo) and potential parents whose germ cells were used for fertilization, or a single woman for which the bearing and birth of a child is not possible for medical reasons.
  3. A surrogate mother may be a woman aged 20 to 40 years, having at least one biological child and a medical certificate on a satisfactory state of health, mentally and somatically healthy, who has undergone medical and genetic counseling.

Chapter 2. The procedure and conditions for using the method of surrogacy

  1. Citizens for medical reasons have the right to parenthood using the method of surrogacy. The use of the surrogacy method is possible only on the basis of a notarized surrogacy agreement (hereinafter the contract). In the event that the surrogate mother is in a marriage, the written consent of the spouse to conclude an agreement is necessary. The contract is concluded between spouses or persons representing their interests, and the woman (surrogate mother) who agreed to implant the embryo in order to bear the fetus and give birth to a child, regardless of the term of his birth. A surrogate mother cannot be an egg donor at the same time.
  2. A surrogate mother is obliged to get medical records early in pregnancy (up to 12 weeks), regularly observe and strictly follow the doctor’s recommendations, constantly monitor her health, abstain from smoking, using drugs, psychotropic substances and alcohol, if separated residence from spouses – inform them about the course of pregnancy.
  3. Spouses who consented to the implantation of a surrogate mother embryo bear the material costs associated with her recovery during pregnancy, childbirth and the postpartum period, in accordance with the contract.
  4. Persons who are married to each other and have concluded an agreement on the implantation of an embryo by another woman for the purpose of bearing him, in the event of the birth of a child, are recorded by his parents in the civil registry book.
  5. Spouses who have concluded an agreement with a surrogate mother are not entitled to refuse the child until he is registered in his name in the civil registry book.
  6. In the event of the birth of a dead child or the abandonment of a child of persons who have concluded an agreement with a surrogate mother, they are not entitled to demand from the surrogate mother any reimbursement of any material costs associated with paying for the medical services of the surrogate mother, as well as the amount of remuneration, if any.
  7. Medical indications for the use of surrogacy are:
  • absence of the uterus (congenital or acquired);
  • deformation of the cavity or cervix with congenital malformations or as a result of a disease;
  • endometrial pathology (synechia, uterine cavity obliteration, endometrial atrophy);
  • unsuccessful repeated attempts of in vitro fertilization (more than 3) with repeated receipt of good quality embryos, the transfer of which does not lead to pregnancy;
  • habitual miscarriage (more than 3 spontaneous miscarriages in history).
  1. When implementing the surrogacy program, the basic in vitro fertilization program consists of the following steps:
  • synchronization of the menstrual cycles of the genetic mother and the surrogate mother;
  • stimulation of superovulation of the genetic mother;
  • obtaining oocytes of the genetic mother;
  • insemination of oocytes of the genetic mother with specially prepared sperm of the husband (partner) or donor;
  • cultivation of embryos;
  • transfer of embryos into the uterine cavity of a surrogate mother (no more than 2 embryos should be transferred, the decision to transfer 3 embryos is made by the surrogate mother by giving written informed voluntary consent after providing the complete information by the attending physician).

Approved by the
Decree of the Government of the Kyrgyz Republic
of July 23, 2018 No. 337 

The procedure
for artificial insemination

Chapter 1. General Provisions

  1. This Procedure for artificial insemination (hereinafter referred to as the Procedure) determines the procedure for artificial insemination using methods of assisted reproductive technologies.
  2. The following concepts are used in this Procedure:
  • assisted reproductive technologies– the collective name of medical technologies, treatment methods and procedures aimed at achieving pregnancy by the patient, in which some or all stages of conception are carried out outside the body of the expectant mother;
  • insemination– a method of artificial insemination by artificially introducing male germ cells into the uterine cavity for the purpose of fertilization;
  • implantation of an embryo by injection of a sperm into the oocyte cytoplasm– assisted reproductive technology, which consists in selecting one high quality male sperm and injecting it directly into the female egg;
  • In vitro fertilization– assisted reproductive technology, which consists in combining the sperm and the egg outside the body of a woman, the development of the embryo formed as a result of this compound and the further transfer of this embryo to the uterus.
  1. A man and a woman, both married and unmarried, have the right to use assisted reproductive technologies in the presence of mutual informed voluntary consent to medical intervention (hereinafter referred to as patients). A single woman is also entitled to the use of assisted reproductive technologies if she has informed consent to medical intervention.
  2. Artificial insemination is carried out by the following methods of infertility treatment, used in the implementation of some or all stages of conception and early development of the embryo outside the body:
  • insemination with sperm;
  • embryo implantation – sperm injection into the cytoplasm of the oocyte;
  • in vitro fertilization.
  1. Information about the performed artificial insemination is a medical secret.
  2. Citizens have the right to information about the artificial insemination procedure, medical and legal aspects of its consequences, data from a medical genetic examination of the donor, external data and the nationality of the donor.

 Chapter 2. The procedure for artificial insemination

  1. In vitro fertilization is performed in assisted reproductive technology clinics. When applying methods of artificial insemination, no more than 2 embryos can be transferred to the uterus of the patient. If the application of artificial insemination methods 3 or more times did not lead to pregnancy, then no more than 3 embryos can be transferred to the patient’s uterus.
  2. In vitro fertilization is carried out in accordance with the clinical protocol approved by the authorized state body of the Kyrgyz Republic in the field of health, and consists of the following stages:
  • stimulation of superovulation;
  • puncture of the ovarian follicles;
  • insemination of oocytes with the sperm of the husband (partner);
  • cultivation of embryos;
  • intrauterine administration (transfer) of embryos;
  • support for the luteal phase of the stimulated menstrual cycle;
  • pregnancy diagnosis.
  1. Indications for insemination with the sperm of the husband (partner) or donor:

1). on the part of the husband (partner):

  • severe violation of spermatogenesis;
  • subfertile sperm;
  • ejaculatory-sexual disorders;
  • high risk of hereditary diseases;

2). on the part of the woman:

  • lack of sexual partner;
  • infertility of cervical origin;

Contraindications for insemination with sperm in women: obstruction of both fallopian tubes and disease (condition) are taken into account in the list, which is approved by the authorized state body of the Kyrgyz Republic in the field of health.

Limitations for insemination with sperm: unsuccessful repeated attempts of insemination with sperm (more than 3 times).

With insemination with sperm, the use of native prepared or cryopreserved sperm is allowed.

The decision to use the sperm of the husband (partner) or donor is made by patients based on the complete information provided by the doctor about the quantitative and qualitative characteristics of the ejaculate, the advantages and disadvantages of using the sperm of the husband (partner) or donor.

Sperm insemination can be used both in the natural cycle and with the use of ovulation and superovulation stimulation (with anovulation) in accordance with the clinical protocols of the authorized public health authority.

  1. Indications for implantation of an embryo by sperm injection into the cytoplasm of an oocyte:
  • severe violation of spermatogenesis;
  • ejaculatory dysfunction;
  • the absence or low percentage of fertilization (less than 20%) of oocytes in the previous program of in vitro fertilization;
  • a small number of oocytes (less than 4).
  • Indications for surgical receipt of sperm:
  • obstructive azoospermia;
  • ejaculatory dysfunction, including retrograde ejaculation.
  • Contraindication for the surgical production of sperm are acute infectious diseases of any localization.

Sources

http://cbd.minjust.gov.kg/act/view/ru-ru/12220